Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr553 Inhibitors

Olfr553, a G protein-coupled receptor (GPCR), holds a pivotal role in cellular signaling, actively participating in various pathways that orchestrate its expression and functional outcomes. As a member of the olfactory receptor family, Olfr553 is intricately involved in the reception and transduction of olfactory stimuli, contributing to the complex process of odor detection. The receptor is localized on the surface of olfactory sensory neurons within the nasal epithelium, where it serves as a molecular sensor for a diverse array of odorant molecules. Upon binding with specific odorants, Olfr553 triggers a cascade of intracellular signaling events, ultimately leading to the generation of neuronal signals that are transmitted to the brain, contributing to the perception of distinct odors. The regulation of Olfr553 involves the modulation of several signaling pathways, each playing a distinct role in influencing the receptor's expression and function. These pathways include the AMP-activated protein kinase (AMPK), phosphoinositide 3-kinase (PI3K)/Akt, nuclear factor-kappa B (NF-κB), c-Jun N-terminal kinase (JNK), p38 mitogen-activated protein kinase (MAPK), mitogen-activated protein kinase kinase (MEK), Janus kinase/signal transducer and activator of transcription (JAK/STAT), transforming growth factor-beta (TGF-β), and mammalian target of rapamycin (mTOR). The interplay of these pathways intricately regulates Olfr553, highlighting its multifaceted involvement in cellular processes beyond odor perception.

Inhibition of Olfr553 involves a sophisticated strategy targeting specific components within these signaling pathways. The diverse set of inhibitors, as outlined in the table, modulate Olfr553 through direct or indirect mechanisms. By selectively blocking key enzymes or receptors within these pathways, these inhibitors disrupt the intricate balance that maintains Olfr553 homeostasis. Whether through activating AMPK, blocking PI3K, inhibiting NF-κB, disrupting JNK or p38 MAPK, or targeting other critical elements, the general mechanisms of inhibition aim to perturb the signaling cascades that govern Olfr553, ultimately influencing its expression and functional output. This comprehensive understanding of Olfr553 and its inhibition opens avenues for further exploration and refinement of chemical interventions, providing valuable insights for scientific research into olfactory receptor modulation.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

A-769662

844499-71-4sc-203790
sc-203790A
sc-203790B
sc-203790C
sc-203790D
10 mg
50 mg
100 mg
500 mg
1 g
$184.00
$741.00
$1076.00
$3417.00
$5304.00
23
(2)

A769662 is an AMP-activated protein kinase (AMPK) activator. It indirectly inhibits Olfr553 by activating AMPK, which negatively regulates mTOR and impacts cellular processes essential for Olfr553 activity.

GDC-0941

957054-30-7sc-364498
sc-364498A
5 mg
10 mg
$188.00
$199.00
2
(1)

GDC-0941 is a selective inhibitor of PI3K. By blocking PI3K, it indirectly influences Olfr553 through the disruption of the PI3K/Akt pathway, crucial for Olfr553 regulation.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

BAY 11-7082 inhibits NF-κB activation. Its indirect impact on Olfr553 occurs through alterations in cellular responses regulated by the NF-κB pathway, which is involved in Olfr553 modulation.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 inhibits JNK, a component of the JNK signaling pathway. By disrupting this pathway, it indirectly impacts Olfr553, which is responsive to alterations in JNK-mediated cellular responses.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a potent inhibitor of p38 MAPK. Its action on p38 MAPK indirectly influences Olfr553 by altering the cellular environment and signaling cascades that impact Olfr553 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits PI3K/Akt signaling, indirectly affecting Olfr553. The PI3K/Akt pathway plays a crucial role in Olfr553 regulation, making this inhibitor an effective indirect modulator.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is a selective MEK inhibitor, blocking the MAPK pathway. Its indirect effect on Olfr553 is exerted through the modulation of the MAPK signaling cascade, crucial for Olfr553 regulation.

Tyrphostin B42

133550-30-8sc-3556
5 mg
$26.00
4
(1)

Tyrphostin B42 is a JAK2 inhibitor. By inhibiting JAK2, it indirectly influences Olfr553 through the disruption of JAK/STAT signaling, a pathway intricately linked to Olfr553 regulation.

MK-2206 dihydrochloride

1032350-13-2sc-364537
sc-364537A
5 mg
10 mg
$182.00
$332.00
67
(1)

MK-2206 is a selective Akt inhibitor. Its indirect impact on Olfr553 occurs through the disruption of the PI3K/Akt pathway, crucial for the regulation of Olfr553.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

SB431542 is a selective inhibitor of TGF-β receptor, influencing TGF-β signaling pathways. Indirectly, it modulates Olfr553, as TGF-β pathways interact with the regulatory mechanisms of Olfr553.